Korean drug firms gear up for domestic competitiveness

Korean pharmaceutical companies are trying hard to improve their local competitiveness, though their efforts are due to the government’s plan to cut drug prices that are expected to fall about 17 percent on average beginning next year.

Currently, prices of original drugs coming off of patent protection cost 80 percent of what they did under patent protection, while generic drugs cost 68 perc...